Lv4
500 积分 2025-09-26 加入
Research progress of VEGFR small molecule inhibitors in ocular neovascular diseases
18小时前
已完结
An assessment of anti-VEGF drugs safety based on real-world data: from popularity to spontaneous reporting in eudravigilance database
3天前
已完结
Strategic delivery of rapamycin and ranibizumab with intravitreal hydrogel depot disrupts multipathway-driven angiogenesis loop for boosted wAMD therapy
3天前
已完结
Elevated Levels of Endoglin, Endostatin, FGF-α, HGF, and Thrombospondin-2 in Aqueous Humor of nAMD Patients
17天前
已完结
Comparative efficacy and safety of faricimab, aflibercept, conbercept, and ranibizumab for neovascular age-related macular degeneration: a systematic review and network meta-analysis
1个月前
已完结
Crosstalk between anti-angiogenic and pro-angiogenic pathways in disease: Mechanisms and therapeutic strategies
1个月前
已完结
Review of type 3 macular neovascularization in age-related macular degeneration: no DRAMA (Deep Retinal Age-related Microvascular Anomalies)
1个月前
已完结
Crosstalk between anti-angiogenic and pro-angiogenic pathways in disease: Mechanisms and therapeutic strategies
1个月前
已完结
Anti-angiogenic biomolecules in neovascular age-related macular degeneration; therapeutics and drug delivery systems
1个月前
已完结
Advancements in age-related macular degeneration treatment: From traditional anti-VEGF to emerging therapies in gene, stem cell, and nanotechnology
1个月前
已完结
皖公网安备34019202002308
